1. 1238TiPA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. (23rd October 2018) Authors: Jabulowsky, R A; Loquai, C; Derhovanessian, E; Mitzel-Rink, H; Utikal, J; Hassel, J; Kaufmann, R; Pinter, A; Diken, M; Gold, M; Heesen, L; Schreeb, K H; Schwarck-Kokarakis, D; Kreiter, S; Gaiser, M R; Jäger, D; Grabbe, S; Türeci, Ö; Sahin, U Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗